SPONSOR
First People's Hospital of Hangzhou
Total Trials
4
Recruiting
4
Phases
Phase 4
Conditions studied: Clostridium Difficile InfectionThromboembolic DiseaseLower Extremity ProblemEndovascular TreatmentSafety IssuesEfficacy, SelfChronic Hepatitis bTenofovir Alafenamide FumarateMotor Neuron Disease (MND)Amyotrophic Lateral Sclerosis (ALS)
First People's Hospital of Hangzhou is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Clostridium Difficile Infection, Thromboembolic Disease, Lower Extremity Problem, Endovascular Treatment.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — First People's Hospital of Hangzhou
How many clinical trials has First People's Hospital of Hangzhou sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by First People's Hospital of Hangzhou, of which 4 are actively recruiting participants. These trials cover conditions including Clostridium Difficile Infection, Thromboembolic Disease, Lower Extremity Problem. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does First People's Hospital of Hangzhou research focus on?
First People's Hospital of Hangzhou clinical trials span Clostridium Difficile Infection, Thromboembolic Disease, Lower Extremity Problem, Endovascular Treatment, Safety Issues, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a First People's Hospital of Hangzhou clinical trial?
To participate in a First People's Hospital of Hangzhou trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all First People's Hospital of Hangzhou trials with current recruitment status updated daily.
Clinical Trials by First People's Hospital of Hangzhou
NCT06703918
Recruiting
Study on Clostridium Difficile Infection in Infants
Clostridium Difficile Infection
NCT04861506
Recruiting
The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.
Thromboembolic Disease
NCT05853718 Phase 4
Recruiting
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
Chronic Hepatitis b
NCT06765499
Recruiting
The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease
Motor Neuron Disease (MND)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology